CME Group Inc (NASDAQ:CME) (Trend Analysis) shares were traded with a tripled volume. The stock closed last trading session at $117.05, up by 4.51%, with a volume of 5,003,498 shares against an average amount for the last three months of 1,375,100.
Stock Performance: Click here for a free comprehensive Trend Analysis Report
CME Group Inc (NASDAQ:CME) stock is currently trading 0.64% below its 52-week-high, 42.97% above its 52-week-low. The 1-year stock price history is in the range of $81.87 – $117.8. CME Group Inc (CME) has a price to earnings ratio of 27.28 versus Financial sector average of 15.9. CME stock price has outperformed the Nasdaq by 25.6%. The Finance company is currently valued at $39720.57 billion, and its share price closed the last trading session at $117.05. The stock has a 50-day moving average of $104.18 and a 200-day moving average of $101.06.
CME Group Inc (CME) current short interest stands at 4.44 million shares. It has remained stable from the same period of last month. Around 2% of the company’s shares, which are float, are short sold. With a 10-days average volume of 2.1 million shares, the number of days required to cover the short positions stand at 2.2 days.
CME is forecasted to report earnings per share of $0.99 and a revenue of $863.4 million for the 4th Quarter of the fiscal year 2016. CME Group Inc (CME) declared last quarter earnings on October 27. The Finance company announced last quarter earnings per share of $1.05 against a consensus Street estimate of $1.04, beating the average estimate by $0.01. The company posted a revenue of $841.7 million compared to an estimation of $850.4 million.
Is this a Trading Opportunity? Click here for a free Trend Analysis Report
There are currently nineteen analysts that cover CME Group Inc stock. Of those nineteen, nine have a Buy rating, eight have a Hold rating and two have a Sell rating. On a consensus basis this yields to an Overweight rating. The consensus target price stands at $106.73.
A recent analyst activity consisted of Jefferies reiterating their Buy stance on August 31. Jefferies increased their price target on CME from $112 to $118. This corresponds to a 0.81% upside from the last closing price. On the date of report, the stock closed at $107.75.
UBS reiterated their Buy stance on July 29, and increased their price target on CME stock from $104 to $114. This corresponds to a 2.61% downside from the last closing price. On the date of report, the stock closed at $101.67.
Another research firm was Sterne Agee CRT who initiated their coverage on the stock with Neutral rating on May 20. Sterne Agee CRT fixed their price target at $90. This translates to a 23.11% downside from the last closing price. On the date of report, the stock closed at $95.31.
CME Group Inc. operates a derivatives exchange that trades futures contracts and options on futures, interest rates, stock indexes, foreign exchange and commodities. The Exchange brings together buyers and sellers of derivatives products on its trading floors, electronic trading platform, and through privately negotiated transactions that it clears.